Project Blog

Feb
06
2023

How ONCORELIEF assists clinicians in their everyday practice?

By oncorelief-manager

Data and Artificial Intelligence (AI) have revolutionized the healthcare industry, enabling personalized medicine. Personalized medicine is a medical model that tailors treatment and prevention plans to individual patients based on their genetic, lifestyle and environmental information. The use of data and AI in personalized medicine provides numerous benefits, including improved patient outcomes, reduced healthcare costs, and better disease management.

Aug
24
2021

ONCORELIEF Intervention planning

By oncorelief-manager

AI solutions in healthcare – benefits and risks

Digitalization causes enormous changes in many parts of the healthcare sector. Clinical staff make good use of smart software tools in therapy planning or quality assured documentation. Researchers utilize advanced AI methods for big data applications. Hobby sportspersons use generic mobile applications for documentation and basic analysis of their exercise activities.

Apr
08
2021

ONCORELIEF’S AI MODELS VERIFICATION

By Spiros

The consortium is happy to announce that has proceeded with the first design of the Artificial Intelligence (AI) models that will be used in ONCORELIEF for predicting a patient’s quality of life. CERTH, SUITE5 and EXUS, in close collaboration with the medical partners, have had a consensus with regard to the features that will be used to train the Machine Learning (ML) models.

Jan
21
2021

ONCORELIEF’s 1st PROTOTYPE

By oncorelief-manager

The Consortium is happy to announce that the implementation of the first prototype of the ONCORELIEF platform has begun and is expected to be delivered until the end of July. It follows a meticulous design that considered a complete set of requirements that meet the initial functionality to be provided to the platform users, namely, the cancer patients, their caregivers, and the Healthcare Professionals.

This project has received funding from the European Union’s Horizon 2020 Framework Programme for Research and Innovation under grant agreement no 875392.
Copyright © 2020 The ONCORELIEF Consortium